Survival and mortality from COVID-19 in Bogota, Colombia during march and july 2020
DOI:
https://doi.org/10.33448/rsd-v9i11.10049Keywords:
SARS-CoV 2; COVID-19; Survival; Mortality; Risk factors.Abstract
Objective: To determine the survival rate of COVID-19 in Bogotá-Colombia between March and July 2020. Materials and Methods: a retrospective cohort study was made in a population infected by COVID-19 in Bogotá from March 6 to July 8, 2020. Incomplete data was excluded and data reported to the INS were used. Infected populations were confirmed via PCR test; the study time starts intiates during onset of symptoms until death or the final time of the cohort. For survival, the actuarial method, the Long-Rank test, was applied. Results: Survival rate on days 1, 10, 20 and 30, is of 100%, 99%, 98% and 96% respectively, (p <0.01) survival rate at 30 days in female sex is 97% and 95% male patients (HR = 1.4 95% CI 1.2-1.6), the 30-day survival rate of hospitalized patients is of 76%, and 100% in non-hospitalized patients (HR = 31.2 95% % 24.4-40), the age group with the lowest survival rate of 63% was the ≥80 years group (HR = 48.4 95% CI 27.5-85.2). Conclusion: The risk factors related to mortality in Bogotá-Colombia are male sex, advanced age, and hospitalization. The last two risk factors mentioned are risk factors known across multiple COVID-19 survival studies in different ethnic groups and locations. Meanwhile, male sex is not an universal risk factor, not seen in certain studies with different populations and ethnic groups.
References
Di Lorenzo, G., & Di Trolio, R. (2020). Coronavirus Disease (COVID-19) in Italy: Analysis of Risk Factors and Proposed Remedial Measures. Frontiers in Medicine, 7. https://doi.org/10.3389/fmed.2020.00140
Escobar, G., Matta, J., Taype-Huamaní, W., Ayala, R., & Amado, J. (2020). Características clínico epidemiológicas de pacientes fallecidos por COVID-19 en un hospital nacional de Lima, Perú. Revista de la Facultad de Medicina Humana, 20(2), 180-185. https://doi.org/10.25176/RFMH.v20i2.2940
Helmy, Y. A., Fawzy, M., Elaswad, A., Sobieh, A., Kenney, S. P., & Shehata, A. A. (2020). The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. Journal of Clinical Medicine, 9(4). https://doi.org/10.3390/jcm9041225
Instituto nacional de cáncer. (2011). Definición de tasa de supervivencia. Recuperado de https://www.cancer.gov/espanol/publicaciones/diccionario/def/tasa-de-supervivencia
Instituto nacional de salud. (2020). COVID -19 en Colombia. Recuperado de https://www.ins.gov.co/Noticias/Paginas/coronavirus-departamento.aspx
Klein, S. L., Dhakal, S., Ursin, R. L., Deshpande, S., Sandberg, K., & Mauvais-Jarvis, F. (2020). Biological sex impacts COVID-19 outcomes. PLOS Pathogens, 16(6), e1008570. https://doi.org/10.1371/journal.ppat.1008570
Klein, S. L., & Flanagan, K. L. (2016). Sex differences in immune responses. Nature Reviews Immunology, 16(10), 626-638. https://doi.org/10.1038/nri.2016.90
Juan Luis Londoño. (2014). Metodología de la investigación epidemiológica (5a. ed). Bogotá, Colombia: El Manual Moderno Colombia.
Mikami, T., Miyashita, H., Yamada, T., Harrington, M., Steinberg, D., Dunn, A., & Siau, E. (2020). Risk Factors for Mortality in Patients with COVID-19 in New York City. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-020-05983-z
Ministerio de salud. (2020). Colombia confirma su primer caso de COVID-19. Recuperado de https://www.minsalud.gov.co/Paginas/Colombia-confirma-su-primer-caso-de-COVID-19.aspx
Ministerio de salud. (2020). Colombia confirma su primera muerte por coronavirus. Recuperado de https://www.minsalud.gov.co/Paginas/Colombia-confirma-primera-muerte-por-coronavirus.aspx
Observatorio de salud Bogotá. (2020). Casos confirmados de COVID -19 en Bogotá D.C. Recuperado de http://saludata.saludcapital.gov.co/osb/index.php/datos-de-salud/enfermedades-trasmisibles/covid19/
Organización mundial de la salud. (2020, octubre 31). Preguntas y respuestas sobre la enfermedad por coronavirus (COVID-19). Recuperado de https://www.who.int /es/emergencies/diseases/novel-coronavirus-2019/advice-for-public/q-a-coronaviruses
Pereira, A. S. et al. (2018). Metodología de la investigación científica. [libro electrónico]. Santa María: UAB / NTE / UFSM. Recuperado de https://www.ufsm.br/ap p/uploads/sites/358/2019/02/Metodologia-da-Pesquisa-Cientifica_final.pdf.
Szklo, M., & Nieto, F. J. (2003). Epidemiología intermedia: Conceptos y aplicaciones. DIAZ DE SANTOS.
Sousa, G. J. B., Garces, T. S., Cestari, V. R. F., Florêncio, R. S., Moreira, T. M. M., & Pereira, M. L. D. (2020). Mortality and survival of COVID-19. Epidemiology and Infection, 148. https://doi.org/10.1017/S0950268820001405
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Carlos Santiago Esteban Rodriguez; Andres Ricardo Lopez Tovar; Gustavo Adolfo Uriza Jaramillo; Edwin Andrés Bustos Rodríguez; Edgar Antonio Ibáñez Pinilla; Jeadran Nevardo Malagón Rojas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
